Why Biodata Markets Fail: Four Structural Barriers to Success

Biodata markets are a dream – they hold the potential for revolutionizing healthcare, research, and more. But several structural barriers stand in their way. They are not philosophical or regulatory; these barriers are inherent to the nature of data itself, preventing the development of a viable market. We delve into these four hurdles that plague biodata markets: provenance, consent, quality, and liability. Let’s understand how addressing these challenges is key to unlocking the full potential of this revolution.